Venous Thromboembolism in Patients with Membranous Nephropathy
- 1 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 7 (1) , 43-51
Abstract
Summary: Background and objectives: The aims of this study were to determine the frequency of venous thromboembolic events in a large cohort of patients with idiopathic membranous nephropathy and to identify predisposing risk factors. Design, setting, participants, & measurements: We studied patients with biopsy-proven membranous nephropathy from the Glomerular Disease Collaborative Network (n=412) and the Toronto Glomerulonephritis Registry (n=486) inception cohorts. The cohorts were pooled after establishing similar baseline characteristics (total n=898). Clinically apparent and radiologically confirmed venous thromboembolic events were identified. Potential risk factors were evaluated using multivariable logistic regression models. Results: Sixty-five (7.2%) subjects had at least one venous thromboembolic event, and this rate did not differ significantly between registries. Most venous thromboembolic events occurred within 2 years of first clinical assessment (median time to VTE = 3.8 months). After adjusting for age, sex, proteinuria, and immunosuppressive therapy, hypoalbuminemia at diagnosis was the only independent predictor of a venous thromboembolic event. Each 1.0 g/dl reduction in serum albumin was associated with a 2.13-fold increased risk of VTE. An albumin level <2.8 g/dl was the threshold below which risk for a venous thromboembolic event was greatest. Conclusions: We conclude that clinically apparent venous thromboembolic events occur in about 7% of patients with membranous nephropathy. Hypoalbuminemia, particularly <2.8 g/dl, is the most significant independent predictor of venous thrombotic risk.Keywords
This publication has 52 references indexed in Scilit:
- Normoalbuminaemia is associated with IgA nephropathy in primary glomerulopathy with nephrotic-range proteinuria in Chinese patientsNephrology Dialysis Transplantation, 2010
- Risk Factors for Venous ThromboembolismCirculation, 2010
- Genetic susceptibility, smoking, obesity and risk of venous thromboembolismBritish Journal of Haematology, 2010
- Interpreting the Jupiter trial: Statins can prevent VTE, but more study is neededCleveland Clinic Journal of Medicine, 2010
- A Randomized Trial of Rosuvastatin in the Prevention of Venous ThromboembolismNew England Journal of Medicine, 2009
- High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic SyndromeCirculation, 2008
- Why should statins prevent venous thromboembolism? A systematic literature search and a call for actionJournal of Thrombosis and Haemostasis, 2006
- Concentration of Three Thrombin Inhibitors in the Nephrotic Syndrome in AdultsNephron, 1986
- Is Membranous Nephropathy Treatable?American Journal of Nephrology, 1981
- Long-term prognosis of idiopathic membranous glomerulonephritisThe American Journal of Medicine, 1979